This dramatic response underscores how quickly political developments can reshape pharmaceutical valuations. Eli Lilly's direct-to-consumer pricing strategy faces particular scrutiny. The company ...
This strategic approach suggests that if top-line expansion remains elusive, the company will focus on margin improvement through process optimization. The timing of this capital expenditure is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback